Nuzenio

Psoriasis Hcplive Hcplive

Psoriasis Hcplive Hcplive entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 9 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Targeting the Pathways: TNF, IL-17, and IL-23 in Psoriasis - HCPLiveHCPLive · Mon, 10 Aug 2026 12:07:08 GMT Socrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Study - HCPLiveHCPLive · Fri, 07 Aug 2026 23:10:36 GMT Treating Adolescent Plaque Psoriasis: Tolerability and Adherence - HCPLiveHCPLive · Fri, 07 Aug 2026 12:11:05 GMT Exploring the Efficacy and Durability of Oral Agents in Psoriasis - HCPLiveHCPLive · Fri, 07 Aug 2026 12:01:05 GMT Consistent Safety Profile of Risankizumab Across Psoriasis and Psoriatic Arthritis - HCPLiveHCPLive · Thu, 06 Aug 2026 12:05:44 GMT Defining On-Treatment Remission in Psoriasis and PsA - HCPLiveHCPLive · Mon, 03 Aug 2026 12:09:30 GMT Breaking Down Silos: Rheum-Derm Collaboration in Psoriasis Care - HCPLiveHCPLive · Mon, 03 Aug 2026 12:09:30 GMT Breaking the Topical Cycle in Plaque Psoriasis Management - HCPLiveHCPLive · Fri, 31 Jul 2026 16:04:07 GMT

Timeline

Mon, 10 Aug 2026 12:07:08 GMTTargeting the Pathways: TNF, IL-17, and IL-23 in Psoriasis - HCPLive

Fri, 07 Aug 2026 23:10:36 GMTSocrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Study - HCPLive

Fri, 07 Aug 2026 12:11:05 GMTTreating Adolescent Plaque Psoriasis: Tolerability and Adherence - HCPLive

Fri, 07 Aug 2026 12:01:05 GMTExploring the Efficacy and Durability of Oral Agents in Psoriasis - HCPLive

Thu, 06 Aug 2026 12:05:44 GMTConsistent Safety Profile of Risankizumab Across Psoriasis and Psoriatic Arthritis - HCPLive

Mon, 03 Aug 2026 12:09:30 GMTDefining On-Treatment Remission in Psoriasis and PsA - HCPLive

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Psoriasis5 live mentions HCPLive4 live mentions Pathways2 live mentions TNF2 live mentions Phase2 live mentions Tolerability2 live mentions Efficacy2 live mentions Durability2 live mentions Oral Agents2 live mentions Risankizumab Across Psoriasis2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Psoriasis Hcplive Hcplive.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.